Boehringer Ingelheim, University of Dundee extend anti-cancer alliance

This article was originally published here

This brings together the expertise of Professor Alessio Ciulli, one of the pioneers in the field of Proteolysis targeting chimeras (PROTACs), based in the School of Life Sciences

The post Boehringer Ingelheim, University of Dundee extend anti-cancer alliance appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply